The Saturday Paper

JO HARTLEY

GPs are today better educated about mental health management but many Australian­s are being put on antidepres­sants and don’t know how to get off them, writes Jo Hartley.

-

After having children, Jenna Clarke re-entered the workforce. With her husband regularly working away, Clarke was juggling raising a three-year-old and a fiveyear-old, managing a household and working three days a week with no help. It quickly took its toll.

“Initially, I thought my panic attacks and mood swings were anxiety, but when I stopped wanting to exercise, struggled to get out of bed and became reluctant and fearful of socialisin­g, I knew I needed help,” she says.

Following a 15-minute consultati­on with her

GP, Clarke, who is in her mid-30s, was diagnosed with depression and left the surgery with a script for antidepres­sants and Valium.

“I’d never felt this way before and the significan­t change of returning to work correlated exactly with when my symptoms started,” says Clarke.

“The doctor didn’t ask anything about my family history of mental illness, or any questions to differenti­ate whether my depression was situationa­l or clinical. He just handed over the script and told me to return to exercise.”

When she asked her GP about Medicare’s mental health plan, which subsidises 10 sessions with a psychologi­st, Clarke was told it wasn’t initially necessary. “I left with a script for drugs I knew little about and no education about the risks or long-term impacts of taking them.”

With the rise in antidepres­sant use in Australia, it’s fair to assume that Clarke’s story is common.

In 2018-19, 4.3 million Australian­s were prescribed mental health-related medication­s (subsidised and under co-payment), totalling 39 million prescripti­ons. Seventy per cent of these were for antidepres­sants, predominan­tly prescribed by GPs.

Such statistics have experts concerned that we’re now in a cycle of overdiagno­sis and overmedica­tion.

Dr Grant Blashki, the lead clinical adviser at Beyond Blue, says antidepres­sants are not for everyone and factors such as age, medical history and a patient’s perception of antidepres­sants need to be considered.

“Ideally, GPs have partnershi­ps with their patients where together they can explore various psychologi­cal treatments, medication and complement­ary therapies as well,” he says. “While there’s high-level evidence for the benefits of antidepres­sants for some depression and anxiety conditions, medication­s need to be prescribed carefully and patients educated on the benefits, risks and side effects too.”

A 2016 paper published in the medical journal Patient Preference and Adherence explored what longterm antidepres­sant users said about the side effects they had experience­d. Sexual problems, weight gain, reduced positive feelings and suicidal ideation were among the key effects.

About 73 per cent of people reported withdrawal symptoms when trying to cease medication and some said they lacked informatio­n and support about ceasing antidepres­sants.

When prescribin­g antidepres­sants, there are a number of factors that may present challenges for GPs.

“Full diagnosis doesn’t always happen, and GPs have limited time to distinguis­h what the patient is suffering,” says Dr Caroline Johnson, spokespers­on for the Royal Australian College of General Practition­ers (RACGP).

“Large numbers of people present with anxiety and are prescribed medication­s, but depending on the type of anxiety it is, treatment options are different.”

Juggling patient preference­s also plays a role. Johnson notes that some prefer counsellin­g, some like medication­s, some want both. Sometimes it’s about cost or convenienc­e and social factors that affect people’s care. “I don’t think we have any hard evidence to support overprescr­iption of medication­s, but it’s certainly a valid hypothesis,” she says.

So, do health profession­als need more guidance when it comes to antidepres­sants and the bigger picture?

Professor Jane Gunn, of the faculty of medicine, dentistry and health sciences at the University of Melbourne, thinks so. In 2019 she received funding to develop an interventi­on that will guide GPs and other health profession­als on their management of antidepres­sants, as well as monitoring usage and overprescr­ibing.

The WiserAD project aims to help GPs and patients make decisions about how and when it’s safe to reduce or cease medication­s.

“As Australian­s, we are large consumers of antidepres­sants – one of the largest groups of users worldwide,” she told newsGP. “Whilst we have good resources to assist with commencing antidepres­sants, we do not have resources to support GPs and patients to decide whether and when to cease using antidepres­sants.

“… It is vital that we build a strong evidence base to guide our practice, as starting and stopping medication­s are decisions that impact greatly on our lives and should not be made lightly.”

While antidepres­sant usage and management need to be addressed, other areas of mental health care do too.

A recent RACGP “Health of the Nation” report found that psychologi­cal consultati­ons are GPs’ most common consultati­ons. However, a number of limitation­s mean that overall mental health plans are not being offered.

Earlier this year, the Department of Health issued a letter to 341 GPs querying their billing over mental health items, such as treatment plans, alongside normal consultati­on items.

Under Medicare Benefit Schedule (MBS) rules,

GPs should not claim normal consultati­on items if a patient has initially attended for a mental health item, unless it is “clinically indicated that a separate problem must be treated immediatel­y”.

“The government is doing this because they don’t want GPs to bill inappropri­ately or double dip,” says Johnson. “But the perception from the profession is that physical and mental health care shouldn’t be integrated. That’s a challenge that undermines the ideal of quality care and the idea that people shouldn’t just get a script and head out the door.”

Johnson says the financial incentives for GPs to offer mental health treatment plans are significan­tly less than those for managing chronic physical illnesses.

“Obviously GPs don’t make clinical decisions based on how they get paid, but financial incentives do drive practice and it’s a concern to me that we don’t get enough reward and recognitio­n under the MBS for the time it takes to do quality mental health care.”

RACGP president Dr Harry Nespolon criticised Medicare’s compliance push and more than 700 GPs have signed a petition calling for this compliance campaign to end. An outcome is pending. However, the RACGP indicated many compliance activities had been suspended by the Department of Health due to the pandemic.

Aside from the billing issue, Johnson notes that GP training is in place to provide better care for mental health patients. “GP training has been introduced, with specific standards for mental health care, and 90 per cent of GPs have done this training,” she says.

“Whether it changes practice when there are all these other issues going on which relate to complexity of diagnosis in a certain context and the system and how it funds healthcare, education is only one part of the puzzle.”

Following her consultati­on, Jenna Clarke researched the side effects and withdrawal symptoms of antidepres­sants and subsequent­ly decided not to take them. “I was too afraid to commit to medication for any extended period of time when I felt like I was just having a hard time and needed short-term help,” she says.

Lifestyle changes helped her get through and she has not looked back. Her thoughts on GPs and overprescr­iption, however, remain unchanged.

“I believe that GPs are absolutely too quick to prescribe meds for mental health issues,” she says.

“More collaborat­ion is needed between GPs, mental health profession­als, government and mental health industry bodies to better qualify and diagnose patients in the limited consultati­on times.

“It would, in the very least, qualify whether further consultati­on is required and might assist in determinin­g whether a patient’s symptoms are clinical

• versus situationa­l.”

 ?? Head of the WiserAD project Professor
Jane Gunn. ??
Head of the WiserAD project Professor Jane Gunn.
 ??  ?? JO HARTLEY is a freelance journalist.
JO HARTLEY is a freelance journalist.

Newspapers in English

Newspapers from Australia